Article
The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility
13 May 2025
Abstract excerpt
Dysregulation of p53 and phosphoinositide (PIPn) signaling are both key drivers of oncogenesis and metastasis. Our recent findings reveal a previously unrecognized interaction between these pathways, converging in the nucleus to form a PIPn-p53 signalosome that modulates nuclear AKT activation and downstream signaling, thereby influencing cancer cell survival and motility. This review examines recent insights...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
